Aeglea Biotherapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $70k | 4.2k | 16.76 |
| 2025-06-30 | $76k | 5.1k | 14.97 |
| 2025-03-31 | $65k | 4.0k | 16.13 |
| 2024-12-31 | $79k | 3.4k | 23.28 |
| 2024-09-30 | $100k | 3.4k | 29.41 |
| 2024-06-30 | $80k | 3.4k | 23.51 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors